National Institute on Drug Abuse (NIDA)
2,901
330
424
2,095
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.8%
169 terminated/withdrawn out of 2901 trials
92.5%
+6.0% vs industry average
8%
236 trials in Phase 3/4
43%
897 of 2095 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (2901)
Pilot of Mailing Buprenorphine
Role: collaborator
SpinePal Open Pilot
Role: collaborator
Environment and Alcohol: A Pilot Study
Role: lead
Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)
Role: lead
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
Role: lead
Causal Mechanisms of Odor-Guided Behavior in Humans
Role: lead
High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)
Role: collaborator
SMART-r: Substance Monitoring and Active Relapse Tracking Repository
Role: lead
Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl
Role: lead
Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder
Role: lead
Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making
Role: lead
mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care
Role: collaborator
iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers
Role: collaborator
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 1
Role: collaborator
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
Role: collaborator
The Feasibility of Using the PulsePoint to Facilitate Overdose Education and Naloxone Distribution
Role: collaborator
Adaptation and Testing of a Novel Text-based Tobacco Cessation and Education Intervention in Kenyan Emergency Department Patients
Role: collaborator
FostrSpace-CASA R61/R33
Role: collaborator
Infectious Disease (ID) Testing OUtreach in Carceral Hubs
Role: collaborator
Developing Field Tools for Real-Time Assessment of Exposure to Psychosocial Stress and Drug Use in an Outpatient Treatment Population
Role: lead